Re-operation of tricuspid regurgitation after mitral valve replacement with rheumatic heart disease
10.3760/cma.j.issn.1008-6315.2014.01.027
- VernacularTitle:风湿性心脏病二尖瓣置换术后三尖瓣返流的再手术治疗
- Author:
Youqiao LUO
;
Haining FANG
;
Wei TAN
;
Shusong LI
;
Huiqing CAO
;
Jichang LAI
- Publication Type:Journal Article
- Keywords:
Rheumatic heart disease;
Heart valve replacement;
Tricuspid regurgitation;
Surgical treatment
- From:
Clinical Medicine of China
2014;30(1):82-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze clinical manifestation and investigate therapy effect of re-operation of tricuspid regurgitation (TR) after mitral valve replacement with rheumatic heart disease.Methods Seventeen cases with rheumatic heart disease recurred TR after mitral valve replacement surgery,underwent tricuspid valve surgery again in the Third People's Hospital of Nanchang from January 2000 to December 2011.Of 17 cases,10cases underwent tricuspid valve annuloplasty including 1 case for pure De Vega plasty,9 cases for the valve leaflets forming + artificial valve ring forming.Another 7 cases underwent tricuspid valve replacement surgery including 4 cases for biological valve replacement and 3 cases for mechanical valve.Retrospective analyzed the clinical manifestations,treatment process and condition of prognosis.Results One case was with early postoperative deaths (5.88％,1717),and died of postoperative left ventricular failure.Three cases were postoperative low cardiac output syndrome,2 cases were renal insufficiency,and 2 cases were respiratory insufficiency,all those cases were successfully cured.Sixteen cases were followed up from 3 months to 9 years and 2 cases were lost.Of 14,2 cases were NYHA class Ⅰ,8 cases for grade Ⅱ,4 cases for grade Ⅲ.Conclusion After mitral valve replacement in patients with rheumatic heart disease,TR in patients with reoperation is a suitable choice.Reasonable surgical indications,timing of surgery and good perioperative management are the keys to improve the success rate of surgery.
